A common feature in the Alzheimer's disease (AD) brain is the presence of
acetylcholinesterase (AChE) which is commonly associated with β-amyloid plaques and …

Alzheimer's disease (AD) is well-known as a severe neurodegeneration disease involving
complicated etiologies, and cholinesterase inhibition remain the prevailing mode of clinical …

Background: Acetylcholinesterase (AChE) is involved in the termination of impulse
transmission by rapid hydrolysis of the neurotransmitter acetylcholine in numerous …

Autism spectrum disorder (ASD) is a childhood neurodevelopmental disorder. During fetal
and neonatal brain development, the cues for neurodevelopment are regulated in a well …

Cadmium is a neurotoxic compound which induces cognitive alterations similar to those
produced by Alzheimer's disease (AD). However, the mechanism through which cadmium …

In Alzheimer's disease (AD), the enzyme acetylcholinesterase (AChE) co‐localizes with
hyperphosphorylated tau (P‐tau) within neurofibrillary tangles. Having demonstrated that …

Alzheimer's disease (AD) is the most common form of dementia. Notably, patients with AD
often suffer from severe sarcopenia. However, their direct link and relationship remain poorly …

Abstract Bisphenol-A (BPA), a widely used plasticizer, induces cognitive dysfunctions
following single and repeated exposure. Several studies, developed in hippocampus and …

AChE enzymatic inhibition is a core focus of pharmacological intervention in A lzheimer's
disease (AD). Yet, AChE has also been ascribed non‐hydrolytic functions, which seem …

The leading Alzheimer's disease (AD) therapeutics to date involves inhibitors of
acetylcholinesterase (AChE), which should, in principle, elevate cholinergic signaling and …